My Size Proxy Reveals Zero Equity Awards for Executives, Non-Executives
Ticker: MYSZ · Form: DEF 14A · Filed: Jul 8, 2025 · CIK: 1211805
| Field | Detail |
|---|---|
| Company | My Size, INC. (MYSZ) |
| Form Type | DEF 14A |
| Filed Date | Jul 8, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Executive Compensation, Equity Awards, Proxy Statement, Corporate Governance, Software Industry, Talent Retention, Investor Relations
Related Tickers: MYSZ
TL;DR
**MYSZ's zero equity awards for execs and employees is a red flag for future talent and growth; steer clear.**
AI Summary
My Size, Inc. (MYSZ) filed a DEF 14A on July 8, 2025, for its annual meeting scheduled for September 4, 2025. The filing indicates that the grant date fair value of awards granted to 'PeoMember' (presumably executive officers) during 2024 was $0, a decrease from $0 in 2023, suggesting no new equity compensation was issued to this group in either year. Similarly, for 'NonPeoNeoMember' (non-executive officers), the grant date fair value of awards was $0 in both 2024 and 2023. The fair value of all outstanding and unvested awards for 'PeoMember' at the end of 2024 was $0, consistent with 2023, and the same zero value was reported for 'NonPeoNeoMember' for both years. This consistent reporting of zero values for equity awards across both periods and groups suggests a lack of new equity-based compensation or a very specific accounting treatment for such awards, which could impact employee retention and motivation. The company operates in the prepackaged software industry, SIC 7372, and is incorporated in Delaware.
Why It Matters
This DEF 14A filing is crucial for My Size, Inc. investors as it reveals a complete absence of new equity awards for both executive and non-executive personnel in 2023 and 2024. This could signal a strategic shift away from equity-based compensation, potentially impacting employee morale, retention, and the company's ability to attract top talent in the competitive prepackaged software sector. Competitors often use equity to align employee incentives with shareholder value, and My Size's approach could put it at a disadvantage. Investors should scrutinize the rationale behind this compensation strategy and its potential long-term effects on innovation and growth.
Risk Assessment
Risk Level: high — The risk level is high because the filing explicitly states $0 for grant date fair value of awards granted and $0 for fair value of outstanding and unvested awards for both 'PeoMember' and 'NonPeoNeoMember' in 2023 and 2024. This complete lack of equity compensation could severely hinder My Size, Inc.'s ability to attract and retain key talent, especially in the competitive software industry, directly impacting future operational success and shareholder value.
Analyst Insight
Investors should immediately investigate My Size, Inc.'s compensation philosophy and its implications for talent acquisition and retention. Consider reducing exposure to MYSZ until a clear strategy for incentivizing employees and executives is articulated, as the current approach poses significant long-term operational risks.
Key Numbers
- $0 — Grant Date Fair Value of Awards Granted to PeoMember (Reported for both 2024 and 2023, indicating no new equity compensation for executives.)
- $0 — Grant Date Fair Value of Awards Granted to NonPeoNeoMember (Reported for both 2024 and 2023, indicating no new equity compensation for non-executives.)
- $0 — Fair Value of Outstanding and Unvested Awards for PeoMember (At the end of 2024 and 2023, suggesting no unvested equity for executives.)
- $0 — Fair Value of Outstanding and Unvested Awards for NonPeoNeoMember (At the end of 2024 and 2023, suggesting no unvested equity for non-executives.)
- 2025-07-08 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 2024-12-31 — Conformed Period of Report (The fiscal year-end covered by the compensation data in the proxy statement.)
Key Players & Entities
- My Size, Inc. (company) — Registrant filing DEF 14A
- SEC (regulator) — Recipient of DEF 14A filing
- September 4, 2025 (date) — Date of Annual Meeting
- 2024 (date) — Fiscal year for compensation data
- 2023 (date) — Fiscal year for compensation data
- 0001211805 (company) — Central Index Key (CIK) for My Size, Inc.
- Delaware (company) — State of incorporation for My Size, Inc.
- 4 HANEGEV ST, POB 1026, AIRPORT CITY, L3, 7010000 (company) — Business address of My Size, Inc.
- 972-36009030 (company) — Business phone of My Size, Inc.
- 7372 (company) — Standard Industrial Classification (SIC) for Prepackaged Software
FAQ
What is the significance of My Size, Inc. reporting $0 in equity awards for 2023 and 2024?
My Size, Inc. reporting $0 for both grant date fair value of awards granted and fair value of outstanding and unvested awards for 'PeoMember' and 'NonPeoNeoMember' in 2023 and 2024 is highly significant. It indicates a complete absence of new equity-based compensation for both executive and non-executive personnel during these periods, which could negatively impact employee motivation and the company's ability to attract and retain talent.
How might the lack of equity compensation affect My Size, Inc.'s competitive position?
The lack of equity compensation could severely weaken My Size, Inc.'s competitive position within the prepackaged software industry. Many competitors use stock options and restricted stock units to align employee interests with shareholder value and to attract top-tier talent. My Size's current compensation structure, as indicated by the $0 equity awards, may make it difficult to compete for skilled professionals.
When is My Size, Inc.'s annual meeting scheduled?
My Size, Inc.'s annual meeting is scheduled for September 4, 2025, at 10:00 a.m. local time. This information is provided in the Notice of Annual Meeting section of the DEF 14A filing.
What is My Size, Inc.'s primary business classification?
My Size, Inc. is classified under Standard Industrial Classification (SIC) code 7372, which corresponds to 'SERVICES-PREPACKAGED SOFTWARE'. This indicates their primary business involves developing and selling prepackaged software solutions.
What are the potential investor implications of My Size, Inc.'s compensation strategy?
Investors should be concerned about My Size, Inc.'s compensation strategy, specifically the absence of equity awards. This could lead to higher employee turnover, difficulty in recruiting innovative talent, and a potential disconnect between employee performance and shareholder returns, ultimately impacting the company's long-term growth prospects and stock performance.
Has My Size, Inc. changed its name recently?
Yes, My Size, Inc. has undergone name changes. The filing indicates a former name of Mysize Inc. with a date of name change on March 17, 2015, and an even earlier former name of TOPSPIN MEDICAL INC with a date of name change on December 26, 2002.
Where is My Size, Inc. incorporated?
My Size, Inc. is incorporated in the state of Delaware. This information is part of the company data section within the DEF 14A filing.
What is the fiscal year end for My Size, Inc.?
The fiscal year end for My Size, Inc. is December 31. This is consistent with the conformed period of report for the compensation data, which is December 31, 2024.
What is the Central Index Key (CIK) for My Size, Inc.?
The Central Index Key (CIK) for My Size, Inc. is 0001211805. This unique identifier is used by the SEC to identify entities that file disclosures.
How does the DEF 14A filing define 'PeoMember' and 'NonPeoNeoMember' in the context of compensation?
While the DEF 14A filing does not explicitly define 'PeoMember' and 'NonPeoNeoMember' in plain language, standard SEC proxy statement conventions suggest 'PeoMember' refers to Named Executive Officers (PEO - Principal Executive Officer and other NEOs) and 'NonPeoNeoMember' refers to non-executive officers or other employees, distinguishing between those subject to specific executive compensation disclosure rules and other personnel.
Industry Context
My Size, Inc. operates within the prepackaged software industry (SIC 7372). This sector is characterized by rapid technological advancements, intense competition, and evolving customer demands for integrated solutions. Companies in this space often focus on innovation, subscription-based models, and cloud-based services to maintain market share and drive growth.
Regulatory Implications
As a publicly traded company, My Size, Inc. is subject to SEC regulations, including timely and accurate filing of proxy statements (DEF 14A). The disclosure of executive compensation and corporate governance practices is crucial for investor confidence and compliance. Any misstatements or omissions could lead to regulatory scrutiny and penalties.
What Investors Should Do
- Investigate the rationale behind the zero equity compensation.
- Review other compensation components for executives.
- Monitor future filings for changes in compensation strategy.
Key Dates
- 2025-09-04: Annual Meeting — This is the date of the annual meeting where shareholders will vote on company matters, including the election of directors and other proposals. The proxy statement provides information to aid shareholders in their voting decisions.
- 2025-07-08: DEF 14A Filing — The filing of the Definitive Proxy Statement with the SEC, providing detailed information about the annual meeting, executive compensation, corporate governance, and other relevant matters to shareholders.
- 2024-12-31: Conformed Period of Report — This date represents the end of the fiscal year for which the compensation and other financial information in the proxy statement is reported.
Glossary
- DEF 14A
- A Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission (SEC) by publicly traded companies. It contains detailed information about matters to be discussed at the company's annual meeting of shareholders, including executive compensation, board of directors, and corporate governance. (This is the primary document analyzed, providing insights into My Size, Inc.'s corporate governance and executive compensation practices for the reporting period.)
- PeoMember
- Likely refers to 'Principal Executive Officer' or 'Key Executive' members of the company. In the context of a DEF 14A, this group typically includes the highest-ranking officers. (The compensation and awards granted to this group are a key focus for investors assessing management incentives and performance.)
- NonPeoNeoMember
- Likely refers to 'Non-Principal Executive Officer' or 'Other Executive' members, excluding the top executives. This group may include other officers or key management personnel. (Compensation for this group provides a broader view of the company's incentive structures beyond the top leadership.)
- Grant Date Fair Value of Awards Granted
- The estimated fair value of stock options, restricted stock units, or other equity awards on the date they are granted to employees. This is typically calculated using option-pricing models. (The absence of this value for both 2023 and 2024 for all reported groups suggests no new equity compensation was issued, which can impact employee motivation and retention.)
- Fair Value of Outstanding and Unvested Awards
- The total estimated fair value of equity awards that have been granted but have not yet vested as of a specific date (in this case, the end of the fiscal year). (The reported zero value for both 2023 and 2024 indicates no outstanding unvested equity awards for any executive or non-executive groups, reinforcing the lack of equity-based compensation.)
Year-Over-Year Comparison
This DEF 14A filing for the period ending December 31, 2024, shows a continuation of the compensation trends from the prior year. Notably, the grant date fair value of awards granted to both 'PeoMember' and 'NonPeoNeoMember' remains $0 for both 2024 and 2023. Similarly, the fair value of outstanding and unvested awards for these groups also remained at $0 in both years. This consistent lack of equity-based compensation suggests no significant changes in the company's incentive structure for its key personnel between the two reporting periods.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on July 8, 2025 regarding My Size, Inc. (MYSZ).